The government announced earlier that it would start the third dose of the new crown vaccine. The Hong Kong Hospital Pharmacists’ Association conducted an online questionnaire survey through the Hong Kong Institute of Public Opinion. It found that 70 adults said that “the effectiveness of the new crown vaccine” was to choose a vaccine for them. The main consideration at the time.
In addition, before the start of the vaccination plan, the association used a questionnaire survey to understand the public’s attitudes towards vaccines. At that time, 54% said they preferred Fubitai vaccine. However, after 10 months, this survey showed that they chose to retake the vaccine. The number of people in Bitex has increased to 86%, and only 3% choose Kexing Vaccine.
In addition, among those who did not receive a shot, 47% said they would not get the shot, 24% said they did not decide, and 21% said they would get the shot sooner or later, but did not plan when they would get the shot.
From October to November this year, the Hong Kong Institute of Hospital Pharmacists conducted an online questionnaire survey through the Hong Kong Institute of Public Opinion to understand Hong Kong people’s willingness to vaccinate the new crown vaccine booster. A total of 5,644 successful responses were collected, of which 61% had been vaccinated. The remaining 39% had never received an injection.
Among those who did not get the shot, 47% said they would not get the shot, 24% said they did not decide, and 21% said they would get the shot sooner or later, but they did not plan when they would get the shot.
In addition, in early January this year, the Society launched a questionnaire survey before the start of the vaccination plan. Among 596 vaccine manufacturers who filled out the questionnaire, 54% chose Fubitai, 28% chose Kexing, and 13% chose AstraZeneca.
However, in this survey, 86% of the 4,605 respondents who had been vaccinated or planned to vaccinate said they chose Fubitai, which means an increase of 50% within 10 months, but only 3% chose Kexing.
Infection and Infectious Diseases Specialist Lin Weixun said that 70 adults said that "the effectiveness of the new crown vaccine" was their main consideration when choosing a vaccine, followed by "what international recognition is the new crown vaccine obtained?" (62%) and "production". The place of the new crown vaccine (55%). He believes that the related reason may be the reason why the public chose Fubitai.
▼12.3 New Crown Vaccine Mobile Vaccination Station Launch Ceremony▼
+18
Omicron｜Zhong Nanshan: Not so terrible, the existing vaccines are still protective of new coronary pneumonia｜The former Queen of the Netherlands was vaccinated with a booster before the diagnosis of 83 years old